• DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
  • DNDi_Logo_No-Tagline_Full Colour
  • Our work
    • Diseases
      • Sleeping sickness
      • Visceral leishmaniasis
      • Cutaneous leishmaniasis
      • Chagas disease
      • Filaria: river blindness
      • Mycetoma
      • Paediatric HIV
      • Cryptococcal meningitis
      • Hepatitis C
      • Dengue
      • Pandemic preparedness
      • Antimicrobial resistance
    • Research & development
      • R&D portfolio & list of projects
      • Drug discovery
      • Translational research
      • Clinical trials
      • Registration & access
      • Treatments delivered
    • Advocacy
      • Open and collaborative R&D
      • Transparency of R&D costs
      • Pro-access policies and IP
      • Children’s health
      • Gender equity
      • Climate change
      • AI and new technologies
  • Networks & partners
    • Partnerships
      • Our partners
      • Partnering with us
    • Global networks
      • Chagas Platform
      • Dengue Alliance
      • HAT Platform
      • LEAP Platform
      • redeLEISH Network
    • DNDi worldwide
      • DNDi Switzerland
      • DNDi DRC
      • DNDi Eastern Africa
      • DNDi Japan
      • DNDi Latin America
      • DNDi North America
      • DNDi South Asia
      • DNDi South-East Asia
  • News & resources
    • News & stories
      • News
      • Stories
      • Statements
      • Viewpoints
      • Social media
      • eNews Newsletter
    • Press
      • Press releases
      • In the media
      • Podcasts, radio & TV
      • Media workshops
    • Resources
      • Scientific articles
      • Our publications
      • Videos
    • Events
  • About us
    • About
      • Who we are
      • How we work
      • Our strategy
      • Our donors
      • Annual reports
      • Our prizes and awards
      • Our story: 20 years of DNDi
    • Our people
      • Our leadership
      • Our governance
      • Contact us
    • Work with us
      • Working at DNDi
      • Job opportunities
      • Requests for proposal
  • Donate
Home > News

Scientific community, managers, specialists, and people affected by Chagas launch manifesto to advance control of the disease as a public health problem

Home > News

Scientific community, managers, specialists, and people affected by Chagas launch manifesto to advance control of the disease as a public health problem

Woman standing in rural setting
23 Sep 2022
  • English
    • English
    • Español
    • Português

On 23 September 2022, members of the Chagas Disease Clinical Research Platform and the Global Chagas Coalition, attending the 10th Meeting of the Chagas Platform in Bogotá, Colombia, agreed to a manifesto that is addressed to governments, organizations, funders, and other stakeholders involved in the fight against Chagas disease. The document sets out priorities for action and calls for intensified efforts to achieve the elimination of Chagas disease as a public health problem, as stipulated in the WHO 2030 NTD Roadmap and PAHO’s Neglected Infectious Diseases Elimination Initiative, both aligned with the United Nations Sustainable Development Goals.

The manifesto comes after deep reflection by the scientific community, health programme managers, specialists, and people affected by the disease. It is a joint effort to update the commitments and efforts that must be undertaken in the coming years, with reference to and replacing the Letter of Santa Cruz from 2018, which has been a milestone to guide efforts to fight against the disease.

The manifesto sets out 6 commitments:

  1. Improve access to diagnosis, treatment, and comprehensive care for people affected by Chagas disease in all its dimensions, guaranteeing the implementation of decentralized comprehensive routes to care, which allow the provision of care and follow-up at the primary healthcare level; adoption of simplified diagnostic algorithms; prioritization of the systematic implementation of screening in women of reproductive age, pregnant women, and infants;
  1. Encourage investment in research and development to obtain simpler, safer diagnostic and therapeutic tools. This includes undertaking research to optimise current diagnostic algorithms and treatment regimens, as well as developing new tools; more progress to discover biomarkers that accurately identify people at risk of progression to organ involvement, and to provide definitive evidence of therapeutic response in chronic patients who have received treatment;
  1. Improve surveillance and control of the disease, expanding systems of mandatory notification of Chagas cases and clinical complications;
  1. Strengthen and facilitate access to training and information resources for both healthcare personnel and affected people, facilitating the provision of up-to-date, high-quality care;
  1. Promote coordination between the various actors involved in providing comprehensive care and guarantee the participation of affected people and their associations in the design and implementation of strategies, which are adapted to the epidemiological and sociocultural contexts of their communities;
  1. Continue to support activities related to World Chagas Day as an opportunity to highlight global efforts to reduce the impact of Chagas disease, as well as promote actions to improve access to comprehensive care.

Read the Bogotá manifesto

Photo credit: Fábio Nascimento-DNDi

Registration & access Universal Health Coverage Strengthening Capacities Chagas disease Colombia Latin America

Read, watch, share

Loading...
News
6 Jun 2025

DNDi is partnering with Médecins Sans Frontières South Asia for the Without Borders Media Fellowship 2025 

News
5 Jun 2025

Meet the DNDi Eastern Africa 2024-2025 Media Fellows

Press releases
5 Jun 2025

Colombia becomes first country to recommend rapid tests to diagnose Chagas disease

Statements
27 May 2025

DNDi interventions at the 78th World Health Assembly

Press releases
22 May 2025

Six African nations commit to eliminate deadly neglected disease visceral leishmaniasis

Videos
20 May 2025

The Children of the Sierra

Press releases
13 May 2025

First all-oral treatment for a rare but deadly strain of sleeping sickness now available and being used to treat patients in endemic countries in Africa

Statements
8 May 2025

DNDi’s briefing note for 78th World Health Assembly

VIEW ALL

Help neglected patients

To date, we have delivered thirteen new treatments, saving millions of lives.

Our goal is to deliver 25 new treatments in our first 25 years. You can help us get there. 

GIVE NOW
Linkedin-in Instagram Twitter Facebook-f Youtube
International non-profit developing safe, effective, and affordable treatments for the most neglected patients.

Learn more

  • Diseases
  • Neglected tropical diseases
  • R&D portfolio
  • Policy advocacy

Get in touch

  • Our offices
  • Contact us
  • Integrity Line

Support us

  • Donate
  • Subscribe to eNews

Work with us

  • Join research networks
  • Jobs
  • RFPs
  • Terms of Use   
  •   Acceptable Use Policy   
  •   Privacy Policy   
  •   Cookie Policy   
  •   Our policies   

  • Except for images, films and trademarks which are subject to DNDi’s Terms of Use, content on this site is licensed under a Creative Commons Attribution-NonCommercial-Share Alike 3.0 Switzerland License